Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immunoglobulin Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Not Yet RecruitingNCT07796100
What this trial is testing

ZL-1310 in Combination With a Checkpoint Inhibitor Versus Standard of Care Platinum Based Chemotherapy With a Checkpoint Inhibitor as First-line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Extensive-Stage Small Cell Lung Cancer
Zai Lab (Shanghai) Co., Ltd. 530
Testing effectiveness (Phase 2)Ended earlyNCT00547066
What this trial is testing

Study of Veltuzumab (hA20) at Different Doses in Patients With ITP

Who this might be right for
Purpura, Thrombocytopenic, IdiopathicAutoimmune Thrombocytopenic PurpuraPurpura, Thrombocytopenic, Autoimmune
Gilead Sciences 48
Large-scale testing (Phase 3)Not Yet RecruitingNCT07807995
What this trial is testing

Open-Label Study of Long-term Treatment With Povetacicept in Adults With Immunoglobulin A Nephropathy

Who this might be right for
Immunoglobulin A Nephropathy
Vertex Pharmaceuticals Incorporated 605
Large-scale testing (Phase 3)Active Not RecruitingNCT05687266
What this trial is testing

Phase III, Open-label, First-line Study of Dato-DXd in Combination With Durvalumab and Carboplatin for Advanced NSCLC Without Actionable Genomic Alterations

Who this might be right for
NSCLC
AstraZeneca 1,350
Early research (Phase 1)Study completedNCT02788175
What this trial is testing

Vedolizumab (Anti-alpha4beta7) in Subjects With HIV Infection Undergoing Analytical Treatment Interruption

Who this might be right for
HIV
National Institute of Allergy and Infectious Diseases (NIAID) 26
Early research (Phase 1)Ended earlyNCT03169894
What this trial is testing

Evaluation of the Safety, Tolerability, and Efficacy of MDGN-002 in Adults With Moderate to Severe Active Crohn's Disease or Ulcerative Colitis

Who this might be right for
Crohn DiseaseUlcerative Colitis
Avalo Therapeutics, Inc. 8
Not applicableUnknownNCT05201729
What this trial is testing

Influence Factors of PD-1 Therapeutic Efficacy in Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Ductal Adenocarcinoma, PDAC
Ruijin Hospital 30
Testing effectiveness (Phase 2)Looking for participantsNCT06094881
What this trial is testing

A Prospective, One-arm and Open Clinical Study of Obinutuzumab in the Treatment of Pediatric Primary Immune Thrombocytopenia (ITP)

Who this might be right for
Immune ThrombocytopeniaTreatment
Institute of Hematology & Blood Diseases Hospital, China 60
Early research (Phase 1)Study completedNCT00793975
What this trial is testing

Study of IMC-1121B in Patients With Tumors That Have Not Responded to Therapy

Who this might be right for
Advanced Solid Tumors
Eli Lilly and Company 37
Post-approval studies (Phase 4)Study completedNCT06806657
What this trial is testing

Safety Study in Subjects ≥ 12 Years of Age With Hereditary Angioedema Switching to Garadacimab

Who this might be right for
Hereditary Angioedema
CSL Behring 18
Testing effectiveness (Phase 2)Looking for participantsNCT07151690
What this trial is testing

BCMA/CD3 Bispecific Antibody Treatment for Newly Diagnosed Amyloidosis

Who this might be right for
Systemic Light Chain Amyloidosis
Institute of Hematology & Blood Diseases Hospital, China 21
Large-scale testing (Phase 3)UnknownNCT04915482
What this trial is testing

TPO-RAs Combined With Anti-CD20 Antibody in the Treatment of Adult Immune Thrombocytopenia With Autoantibodies

Who this might be right for
Immune Thrombocytopenia (ITP)AutoantibodiesEvan Syndrome+1 more
Institute of Hematology & Blood Diseases Hospital, China 94
Early research (Phase 1)Ended earlyNCT02757391
What this trial is testing

CD8+ T Cell Therapy and Pembrolizumab in Treating Patients With Metastatic Gastrointestinal Tumors

Who this might be right for
Colorectal AdenocarcinomaMetastatic CholangiocarcinomaMetastatic Colorectal Carcinoma+10 more
M.D. Anderson Cancer Center 1
Testing effectiveness (Phase 2)UnknownNCT03967925
What this trial is testing

Rituximab and Belimumab Combination Therapy in PR3 Vasculitis

Who this might be right for
ANCA Associated VasculitisGranulomatosis With Polyangiitis
Rachel Jones 31
Not applicableUnknownNCT04782089
What this trial is testing

Study of PD-1 Antibody and PARP Inhibitor in Extensive Stage Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
Qilu Hospital of Shandong University 20
Testing effectiveness (Phase 2)UnknownNCT03171220
What this trial is testing

Neoantigen Reactive T Cells Combined With SHR-1210 for Chinese Patients With Advanced Refractory Solid Tumors

Who this might be right for
Advanced Malignant Solid Tumor
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 40
Not applicableLooking for participantsNCT06287268
What this trial is testing

Revolade Tablets Specified Drug-use Survey

Who this might be right for
Aplastic Anemia
Novartis Pharmaceuticals 10
Very early researchLooking for participantsNCT07526350
What this trial is testing

MTS109 in Patients With Refractory Autoimmune Diseases

Who this might be right for
Systemic Lupus ErythematosusIdiopathic Inflammatory MyopathiesSystemic Sclerosis (SSc)+2 more
Shanghai Changzheng Hospital 15
Large-scale testing (Phase 3)Study completedNCT00003280
What this trial is testing

Monoclonal Antibody Therapy in Treating Patients With Follicular or Mantle Cell Lymphoma

Who this might be right for
Lymphoma
Swiss Cancer Institute 240
Early research (Phase 1)WithdrawnNCT05823480
What this trial is testing

Magrolimab in Combination with Azacitidine After Allogeneic HCTin Treating Patients with High-Risk AML or MDS

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndrome
City of Hope Medical Center
Next Page